SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-005944
Filing Date
2021-01-28
Accepted
2021-01-28 20:00:11
Documents
1
Period of Report
2021-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4414
  Complete submission text file 0001209191-21-005944.txt   5980
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 3721 VALLEY CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Dube Eric M (Reporting) CIK: 0001763494 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36257 | Film No.: 21567423